Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA repair protein RAD52 homolog (RAD52) is a conserved DNA repair factor central to the maintenance of genome integrity. RAD52 facilitates the annealing of complementary single-stranded DNA during repair of double-strand breaks by single-strand annealing and serves as a backup mediator for homologous recombination, especially in cells deficient in canonical HR proteins such as BRCA1/2 or PALB2[1][2][5]. Structurally, RAD52 forms heptameric or undecameric rings via its N-terminal domain, mediating DNA binding and annealing, while its intrinsically disordered C-terminal tail participates in protein-protein interactions[2][6]. In mammals, RAD52 plays key roles in alternative DNA repair pathways, RNA-templated DNA recombination, break-induced replication, and regulation of replication fork stability[1][3][5][6]. RAD52 is considered a promising therapeutic target, particularly in cancer cells with impaired HR, where its inhibition can induce synthetic lethality[3][1][2]. RAD52 overexpression is linked to tumorigenesis, and targeting RAD52 is a strategy under investigation for the selective eradication of DNA repair-deficient cancers[3][1].
Inhibiting DNA double-strand break repair via SSA and backup HR pathways; Synthetic lethality with BRCA1/2, PALB2, and other HR-deficient tumor cells; Protects replication fork and promotes survival in DNA repair-deficient cancers
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA repair protein RAD52 homolog (RAD52).